simendan has been researched along with Cardiomyopathy, Chagas in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Albernaz Muniz, RZ; de March Ronsoni, R; Feijó, RV; Filho, WJ; Melo, LH; Moro, A; Schwingel, FL; Weber, S | 1 |
1 other study(ies) available for simendan and Cardiomyopathy, Chagas
| Article | Year |
|---|---|
The use of Levosimendan for myocardiopathy due to acute Chagas' disease.
Topics: Acute Disease; Cardiotonic Agents; Chagas Cardiomyopathy; Humans; Hydrazones; Myocarditis; Pyridazines; Simendan | 2009 |